Kanavos P - Search Results

1

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.

Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D, Gore C, Goulis I, Hadziyannis S, Kalamitsis G, Kanavos P, Kautz A, Koskinas I, Leite BR, Malliori M, Manolakopoulos S, Matičič M, Papaevangelou V, Pirona A, Prati D, Raptopoulou-Gigi M, Reic T, Robaeys G, Schatz E, Souliotis K, Tountas Y, Wiktor S, Wilson D, Yfantopoulos J, Hatzakis A. Papatheodoridis G, et al. Among authors: kanavos p. J Viral Hepat. 2016 Feb;23 Suppl 1:1-12. doi: 10.1111/jvh.12493. J Viral Hepat. 2016. PMID: 26809941

2

Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries.

Kanavos P, Visintin E, Gentilini A. Kanavos P, et al. Soc Sci Med. 2023 Aug;331:116045. doi: 10.1016/j.socscimed.2023.116045. Epub 2023 Jun 26. Soc Sci Med. 2023. PMID: 37450991 Free article.

3

Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries.

Mills M, Kanavos P. Mills M, et al. Among authors: kanavos p. Pharmacoecon Open. 2023 Jul;7(4):553-565. doi: 10.1007/s41669-023-00406-1. Epub 2023 Mar 23. Pharmacoecon Open. 2023. PMID: 36952209 Free PMC article.

4

Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries.

Mills M, Michaeli D, Miracolo A, Kanavos P. Mills M, et al. Among authors: kanavos p. BMC Health Serv Res. 2023 Feb 13;23(1):150. doi: 10.1186/s12913-023-09095-2. BMC Health Serv Res. 2023. PMID: 36782175 Free PMC article.

5

A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom.

Angelis A, Montibeller G, Kanavos P. Angelis A, et al. Among authors: kanavos p. Soc Sci Med. 2023 Nov;337:116236. doi: 10.1016/j.socscimed.2023.116236. Epub 2023 Sep 15. Soc Sci Med. 2023. PMID: 37857240 Free article.

6

Road traffic mortality and economic uncertainty: Evidence from the United States.

Kanavos P, Vandoros S. Kanavos P, et al. Soc Sci Med. 2023 Jun;326:115891. doi: 10.1016/j.socscimed.2023.115891. Epub 2023 Apr 6. Soc Sci Med. 2023. PMID: 37100029 Free article.

7

How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe : Better access to medicines through HTA.

Fontrier AM, Kamphuis B, Kanavos P. Fontrier AM, et al. Among authors: kanavos p. Eur J Health Econ. 2024 Aug;25(6):935-950. doi: 10.1007/s10198-023-01637-z. Epub 2023 Nov 2. Eur J Health Econ. 2024. PMID: 37917290 Free PMC article.

8

The economics of blood: gift of life or a commodity?

Kanavos P, Yfantopoulos J, Vandoros C, Politis C. Kanavos P, et al. Int J Technol Assess Health Care. 2006 Summer;22(3):338-43. doi: 10.1017/s0266462306051233. Int J Technol Assess Health Care. 2006. PMID: 16984062

9

Assessing the economic challenges posed by orphan drugs.

Drummond MF, Wilson DA, Kanavos P, Ubel P, Rovira J. Drummond MF, et al. Among authors: kanavos p. Int J Technol Assess Health Care. 2007 Winter;23(1):36-42. doi: 10.1017/S0266462307051550. Int J Technol Assess Health Care. 2007. PMID: 17234015

10

The dynamics of colorectal cancer management in 17 countries.

Kanavos P, Schurer W. Kanavos P, et al. Eur J Health Econ. 2010 Jan;10 Suppl 1:S115-29. doi: 10.1007/s10198-009-0201-2. Eur J Health Econ. 2010. PMID: 20012129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters